 Marcy Yonker
Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Migraine Disorders | 19 | 2023 | 106 | 4.000 |
Why?
| | Headache | 10 | 2023 | 153 | 0.840 |
Why?
| | Nasal Sprays | 1 | 2022 | 6 | 0.770 |
Why?
| | Sleep Wake Disorders | 2 | 2023 | 305 | 0.690 |
Why?
| | Headache Disorders, Secondary | 1 | 2018 | 4 | 0.580 |
Why?
| | Pseudotumor Cerebri | 1 | 2018 | 31 | 0.560 |
Why?
| | Pediatrics | 5 | 2020 | 1102 | 0.520 |
Why?
| | Inpatients | 1 | 2020 | 513 | 0.470 |
Why?
| | Neurology | 3 | 2020 | 112 | 0.430 |
Why?
| | Child | 23 | 2023 | 22390 | 0.420 |
Why?
| | Headache Disorders | 3 | 2020 | 19 | 0.390 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2015 | 237 | 0.380 |
Why?
| | Telemedicine | 1 | 2021 | 893 | 0.360 |
Why?
| | Practice Guidelines as Topic | 4 | 2020 | 1546 | 0.350 |
Why?
| | Disease Management | 1 | 2015 | 634 | 0.340 |
Why?
| | Trigeminal Autonomic Cephalalgias | 1 | 2010 | 1 | 0.330 |
Why?
| | Tension-Type Headache | 1 | 2010 | 9 | 0.330 |
Why?
| | Calcitonin Gene-Related Peptide | 2 | 2020 | 38 | 0.310 |
Why?
| | Academies and Institutes | 2 | 2019 | 54 | 0.300 |
Why?
| | Analgesics | 3 | 2019 | 231 | 0.300 |
Why?
| | Societies, Medical | 3 | 2020 | 859 | 0.250 |
Why?
| | Adolescent | 18 | 2023 | 22116 | 0.250 |
Why?
| | Pain Management | 2 | 2019 | 397 | 0.230 |
Why?
| | Tryptamines | 2 | 2022 | 5 | 0.210 |
Why?
| | Oxazolidinones | 2 | 2022 | 16 | 0.210 |
Why?
| | Musculoskeletal Pain | 1 | 2023 | 39 | 0.200 |
Why?
| | Zinc Compounds | 1 | 2022 | 8 | 0.190 |
Why?
| | Serotonin 5-HT1 Receptor Agonists | 1 | 2022 | 4 | 0.190 |
Why?
| | Administration, Intranasal | 1 | 2022 | 92 | 0.190 |
Why?
| | Antibodies, Monoclonal | 2 | 2020 | 1456 | 0.190 |
Why?
| | Humans | 27 | 2023 | 141284 | 0.190 |
Why?
| | Sulfides | 1 | 2022 | 87 | 0.180 |
Why?
| | White Matter | 1 | 2023 | 146 | 0.170 |
Why?
| | Dopamine Antagonists | 1 | 2020 | 25 | 0.160 |
Why?
| | Double-Blind Method | 2 | 2022 | 1992 | 0.160 |
Why?
| | Cross-Over Studies | 1 | 2022 | 578 | 0.160 |
Why?
| | Neuromuscular Agents | 1 | 2020 | 44 | 0.150 |
Why?
| | Botulinum Toxins, Type A | 1 | 2020 | 55 | 0.150 |
Why?
| | Transition to Adult Care | 1 | 2020 | 92 | 0.150 |
Why?
| | Receptors, Calcitonin Gene-Related Peptide | 1 | 2018 | 4 | 0.150 |
Why?
| | Chronic Pain | 1 | 2023 | 281 | 0.150 |
Why?
| | Anticonvulsants | 3 | 2019 | 222 | 0.150 |
Why?
| | Headache Disorders, Primary | 1 | 2018 | 4 | 0.150 |
Why?
| | Sleep | 2 | 2023 | 882 | 0.140 |
Why?
| | Histamine Antagonists | 1 | 2015 | 20 | 0.120 |
Why?
| | Emergency Service, Hospital | 2 | 2020 | 2210 | 0.110 |
Why?
| | Antidepressive Agents | 2 | 2015 | 243 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1491 | 0.100 |
Why?
| | Treatment Outcome | 4 | 2022 | 11216 | 0.100 |
Why?
| | Antihypertensive Agents | 1 | 2015 | 508 | 0.090 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 1043 | 0.080 |
Why?
| | Research Report | 2 | 2019 | 80 | 0.070 |
Why?
| | Evidence-Based Medicine | 2 | 2019 | 717 | 0.060 |
Why?
| | Adult | 3 | 2023 | 39319 | 0.060 |
Why?
| | Female | 10 | 2023 | 75814 | 0.050 |
Why?
| | Sumatriptan | 2 | 2019 | 6 | 0.050 |
Why?
| | Male | 10 | 2020 | 70140 | 0.050 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2020 | 908 | 0.050 |
Why?
| | Acute Disease | 1 | 2006 | 1005 | 0.050 |
Why?
| | Retrospective Studies | 5 | 2023 | 16447 | 0.040 |
Why?
| | Anxiety Disorders | 1 | 2023 | 370 | 0.040 |
Why?
| | Naproxen | 1 | 2019 | 17 | 0.040 |
Why?
| | Cluster Headache | 1 | 2018 | 1 | 0.040 |
Why?
| | Post-Traumatic Headache | 1 | 2018 | 5 | 0.040 |
Why?
| | Contraindications, Drug | 1 | 2018 | 9 | 0.040 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2018 | 77 | 0.040 |
Why?
| | Comorbidity | 1 | 2023 | 1671 | 0.040 |
Why?
| | Drug Combinations | 1 | 2019 | 365 | 0.030 |
Why?
| | Body Size | 1 | 2018 | 94 | 0.030 |
Why?
| | Consensus | 1 | 2020 | 538 | 0.030 |
Why?
| | Pain Measurement | 2 | 2013 | 555 | 0.030 |
Why?
| | Obesity | 1 | 2009 | 3007 | 0.030 |
Why?
| | Child, Preschool | 3 | 2023 | 11511 | 0.030 |
Why?
| | Patient Selection | 1 | 2018 | 685 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2023 | 5948 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2047 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2018 | 1035 | 0.030 |
Why?
| | Pregnancy Complications | 1 | 2018 | 577 | 0.020 |
Why?
| | United States | 2 | 2019 | 15298 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5653 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 3024 | 0.020 |
Why?
| | History, 21st Century | 1 | 2012 | 218 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5222 | 0.020 |
Why?
| | History, 20th Century | 1 | 2012 | 324 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2023 | 3734 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2018 | 1030 | 0.020 |
Why?
| | Ergot Alkaloids | 1 | 2005 | 1 | 0.010 |
Why?
| | Migraine without Aura | 1 | 2005 | 1 | 0.010 |
Why?
| | Cyproheptadine | 1 | 2005 | 3 | 0.010 |
Why?
| | Pregnancy | 1 | 2018 | 7035 | 0.010 |
Why?
| | Serotonin Receptor Agonists | 1 | 2005 | 26 | 0.010 |
Why?
| | Contraindications | 1 | 2005 | 86 | 0.010 |
Why?
| | Reference Standards | 1 | 2005 | 180 | 0.010 |
Why?
| | Biofeedback, Psychology | 1 | 2005 | 36 | 0.010 |
Why?
| | Antiemetics | 1 | 2005 | 48 | 0.010 |
Why?
| | Complementary Therapies | 1 | 2005 | 92 | 0.010 |
Why?
| | Calcium Channel Blockers | 1 | 2005 | 173 | 0.010 |
Why?
| | Triazoles | 1 | 2005 | 163 | 0.010 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2005 | 227 | 0.010 |
Why?
| | Young Adult | 1 | 2020 | 13727 | 0.010 |
Why?
| | Prevalence | 1 | 2009 | 2795 | 0.010 |
Why?
| | Body Mass Index | 1 | 2009 | 2390 | 0.010 |
Why?
| | Diet | 1 | 2005 | 1277 | 0.010 |
Why?
| | Animals | 1 | 2018 | 37328 | 0.010 |
Why?
| | Aging | 1 | 2005 | 1919 | 0.010 |
Why?
| | Middle Aged | 1 | 2012 | 34658 | 0.000 |
Why?
|
|
Yonker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|